02/14/2025
10:34 AM | CytomX Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
4:58 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4/A | |
02/06/2025
4:54 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:55 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:55 PM | Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
4:57 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:02 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:26 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
2:03 PM | Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
11:28 AM | CytomX Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
08/22/2024
4:58 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CTMX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
08/22/2024
4:59 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:00 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:01 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:01 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
11:15 PM | CytomX Therapeutics (Filer)
| Form EFFECT | |
06/17/2024
3:35 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
4:36 PM | CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:36 PM | CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:31 PM | Ashworth Alan (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:32 PM | CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:33 PM | CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:34 PM | CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
4:34 PM | CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
3:00 PM | Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
| Form SC 13G | |
05/08/2024
3:41 PM | CytomX Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2024
5:06 AM | CytomX Therapeutics (Filer)
| Form DEFA14A | |
04/04/2024
3:31 PM | CytomX Therapeutics (Filer)
| Form DEF 14A | |
04/04/2024
3:33 PM | CytomX Therapeutics (Filer)
| Form DEFA14A | |
03/28/2024
6:12 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
4:15 PM | CytomX Therapeutics (Filer)
| Form PRE 14A | |
03/22/2024
3:27 PM | CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:36 PM | CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:37 PM | BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:38 PM | CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:40 PM | CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:41 PM | CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
3:30 PM | CytomX Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
